Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck
- 31 January 2001
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 37 (1) , 50-56
- https://doi.org/10.1016/s1368-8375(00)00056-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Serum Levels of C-erbB-2 (HER-2/neu) in Patients with Malignant and Non-Malignant DiseasesTumor Biology, 1997
- The Detection of Increased Amounts of the Extracellular Domain of the Epidermal Growth Factor Receptor in Serum During Carcinogenesis in Asbestosis PatientsJournal of Occupational and Environmental Medicine, 1994
- Detection of the extracellular domain of c‐erbB‐2 oncoprotein in sera from patients with various carcinomas: Correlation with tumor markersJournal of Clinical Laboratory Analysis, 1993
- Oral cancer progression and c-erbB-2/neu proto-oncogene expressionCancer Letters, 1992
- Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomasHead & Neck, 1991
- A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomasPathology, 1991
- Expression of epidermal growth factor receptor on oral squamous cell carcinomaBritish Journal of Oral and Maxillofacial Surgery, 1988
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenNature, 1984
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984